A global study led by Paresh Dandona, MD, PhD, found a majority
of patients with Type 1 diabetes who were treated with
dapagliflozin, a Type 2 diabetes medicine, had a significant
decline in their blood sugar levels.
Daniel J. Kosman, PhD, SUNY Distinguished Professor of
biochemistry, has been awarded a five-year, $1.96 million grant
that may lead to advances in understanding the progression of
Researchers in the Department of Medicine have published a study
that identifies a new way to predict which patients may be at a
higher risk for heart failure after undergoing Transcatheter Aortic
Valve Implantation (TAVR).
Umesh Sharma, MD, PhD, assistant professor of medicine, has
received a five-year, $1 million grant from the National Institutes
of Health (NIH) to study galectin-3, a protein involved in heart
Researchers in the Department of Pharmacology and
Toxicology have developed and successfully tested a method for
determining whether promising new multiple sclerosis (MS)
treatments in mice could be effective in humans.
Allen Hoste, working under the guidance of mentor Tracey A.
Ignatowski, PhD, assistant professor of pathology and
anatomical sciences, tied for first place in the undergraduate
poster award at the New York Pharmacology Society
(NYPS) sixth annual scientific meeting.
A preclinical study by researchers in the Department of
Medicine’s Division of Geriatrics and Palliative Medicine has
revealed that brief periods of intense physical activity can be
safely administered at advanced age and has the potential to
James N. Jarvis, MD, clinical professor of pediatrics, will use
an Arthritis Foundation grant to study how genes and environment
work together to influence the immune dysfunction in juvenile
M. Laura Feltri, MD, professor
of biochemistry and neurology, is leading research
to determine whether a new family of molecules prevents
demyelination and nerve degeneration in patients with peripheral